Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05428228 · ClinicalTrials.gov registry record · NA

Clinical Study to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults

A NA study of Dehydration and Exercise Performance, sponsored by Liquid I.V..

Recruiting
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT05428228: Recruiting NA study of Dehydration and Exercise Performance, sponsored by Liquid I.V..

NCT05428228 is a NA study of Dehydration and Exercise Performance that is actively recruiting participants, run by Liquid I.V.. The registered enrollment target is 16 participants, below the 57-participant average among 20 other Dehydration trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05428228, a NA study of Dehydration and Exercise Performance, is actively recruiting participants, sponsored by Liquid I.V..

RECRUITING
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

The aim of the clinical trial is to evaluate the efficacy of two novel hydration products on rehydration following exercise.

Interventions

  • OTHER Placebo
  • OTHER TP1
  • OTHER TP2

Study Locations (1)

Tennessee

  • The University of Memphis - Memphis

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2022-10-01
Est. Completion 2024-09-01
Phase NA
Liquid I.V.

5 total trials

What NCT05428228 shows while recruiting

NCT05428228 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 57-participant average among 20 other Dehydration trials with a reported enrollment target (72% lower).

The record links to 5 conditions, with Dehydration appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT05428228 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT05428228 about?

NCT05428228 is a clinical study titled "Clinical Study to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults". The aim of the clinical trial is to evaluate the efficacy of two novel hydration products on rehydration following exercise.

What is the current status of trial NCT05428228?

This trial is currently recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2022-10-01. Estimated completion is 2024-09-01.

What conditions does trial NCT05428228 study?

This clinical trial studies the following conditions: Dehydration, Exercise Performance, Cognitive Performance, Exercise Recovery, Rehydration.

What interventions are being tested in trial NCT05428228?

The interventions under investigation include: Placebo (OTHER), TP1 (OTHER), TP2 (OTHER).

Who is sponsoring clinical trial NCT05428228?

This trial is sponsored by Liquid I.V., which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05428228 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dehydration

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05428228's enrollment target sits among peer trials

16 18th of 20 higher than 3 of 20 other Dehydration trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Dehydration trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05428228, the US trial registry maintained by the National Library of Medicine. NCT05428228 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.